To address this issue, we first utilized the LSL-KrasG12D; ΔInk4a mice for validating Kras activation after intra-tracheal administration of the Ad-Cre adenovirus and approach which, after 12 weeks gave rise to lung adenocarcinoma (Fig. 5A). Here, KRAS is linked to lung adenocarcinoma.